Evidence map›Paper›PMID 26140447›Full record

ReviewAmerican journal of human genetics2015

Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents.

Jeffrey R Botkin, John W Belmont, Jonathan S Berg, Benjamin E Berkman, Yvonne Bombard, Ingrid A Holm, Howard P Levy, Kelly E Ormond, Howard M Saal, Nancy B Spinner and 2 more

Erratum issued Registry-linked trialAbstract readHistorical ArticleReview
In one paragraph

Review in American journal of human genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT03730870 (Assessment of Pharmacogenomics Testing for Improving Pediatric ADHD Psychopharmacological Treatment), which is not on this map. Cited by 243 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
243citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03730870 naterminatednot on this mapstarted 2019, after this paper: background citation

Assessment of Pharmacogenomics Testing for Improving Pediatric ADHD Psychopharmacological Treatment: A Randomized Controlled Trial

TypeinterventionalSponsorClinical and Translational Genome Research Institute, Inc.Ran2019 to 2020Enrolled21ConditionsAttention Deficit Disorders With HyperactivityArmsPharmacogenomics report
3 · Its place in the literature

Who cites it

243 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Diagnosis, management and treatment of the Alport syndrome - 2024 guideline on behalf of ERKNet, ERA and ESPN.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Guideline
  10. Guideline
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Review
  18. Article
  19. Article
  20. Review

183 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

12 authors.

Jeffrey R BotkinUniversity of Utah, Salt Lake City, UT 84112, USA. Electronic address: jeffrey.botkin@hsc.utah.edu.
John W BelmontBaylor College of Medicine, Houston, TX 77030, USA.
Jonathan S BergUniversity of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Benjamin E BerkmanNational Human Genome Research Institute, Bethesda, MD 20892, USA.
Yvonne BombardUniversity of Toronto, Toronto, ON M5B 1T8, Canada; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON M5B 1W8, Canada.
Ingrid A HolmBoston Children's Hospital, Boston, MA 02115, USA.
Howard P LevyJohns Hopkins University, Baltimore, MD 21205, USA.
Kelly E OrmondStanford University, Stanford, CA 94305, USA.
Howard M SaalCincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Nancy B SpinnerChildren's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Benjamin S WilfondSeattle Children's Hospital, Seattle, WA 98101, USA.
Joseph D McInerneyAmerican Society of Human Genetics, Bethesda, MD 20814, USA.

Funding

North Carolina Clinical Genomic Evaluation by Next-gen Exome Sequencing 2U01HG006487 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BERG, JONATHAN S, POWELL, BRADFORD C. · 2012 to 2021
$22.7M
University of Utah Center for Clinical and Translational ScienceUL1TR001067 · NCATS · UNIVERSITY OF UTAH · PI DERE, WILLARD H., HESS, RACHEL · 2013 to 2017
$19.8M
UCEER: Utah Center for Excellence in ELSI Research P20P20HG007249 · NHGRI · UNIVERSITY OF UTAH · PI BOTKIN, JEFFREY R. · 2013 to 2015
$777k
NCATS NIH HHS UL1 TR001067NHGRI NIH HHS P20 HG007249NHGRI NIH HHS U01 HG006487
6 · The paper itself

Abstract

In 1995, the American Society of Human Genetics (ASHG) and American College of Medical Genetics and Genomics (ACMG) jointly published a statement on genetic testing in children and adolescents. In the past 20 years, much has changed in the field of genetics, including the development of powerful new technologies, new data from genetic research on children and adolescents, and substantial clinical experience. This statement represents current opinion by the ASHG on the ethical, legal, and social issues concerning genetic testing in children. These recommendations are relevant to families, clinicians, and investigators. After a brief review of the 1995 statement and major changes in genetic technologies in recent years, this statement offers points to consider on a broad range of test technologies and their applications in clinical medicine and research. Recommendations are also made for record and communication issues in this domain and for professional education.

Indexed as

AdolescentChildGenetic Carrier ScreeningGeneticsGenetic TestingGenomicsHistory, 20th CenturyHistory, 21st CenturyHumansInfant, NewbornInformed Consent By MinorsMicroarray AnalysisPharmacogenetics

Identifiers

PMID26140447
PMCPMC4570999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.